Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07583069 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Psychosocial Effects of a Trauma-Informed Artificial Intelligence-Supported Chatbot in Adults Newly Diagnosed With Cancer

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Study First Submitted
47 trials monitored
See 1 trial at risk
3,263 trials monitored
See 159 trials at risk
The goal of this clinical trial is to evaluate whether a trauma-informed, artificial intelligence-supported chatbot can reduce psychological distress and unmet psychosocial needs in adults newly diagnosed with cancer.: * Does the chatbot reduce trauma-related distress and anxiety levels compared to standard care? * Does the chatbot decrease unmet psychosocial needs in patients following a new cancer diagnosis? Researchers will compare the chatbot intervention to standard care to determine whether the chatbot provides additional psychosocial benefit. Participants will: * Be randomly assigned to either the chatbot intervention group or the standard care group * Use the chatbot freely for 12 weeks (intervention group only) * Complete questionnaires at baseline, 1 month, and 3 months * Be monitored for any psychological risk indicators during the study period
Trial Details
NCT Number NCT07583069
Lead Sponsor Koç University
Collaborators: The Scientific and Technological Research Council of Turkey
Conditions
(from sponsor)
Cancer, Psychosocial Distress, Trauma and Stress Related Disorders, Anxiety
Related terms Anxiety Disorders, Neoplasms, Trauma and Stressor Related Disorders
Enrollment 62 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov